Account
Insider Insights
11.07.2022
New pharmaceutical updated cost containment measur

This updated bill contains some similar measures to those proposed in March as well as some addition...

Read more
Articles
28.03.2022
Correlating value with price in the US oncology ma...

An affordable and sustainable market access landscape is key to ensure patient access to life-saving...

Read more
Insider Insights
16.03.2022
Offering a price lower

Based on a recent decision by the Interministerial Commission on Medicines Prices offering a price l...

Read more
Insider Insights
24.02.2022
Legislation-extends-CPR-and-CTS-membership

The National Recovery and Resilience Plan had extended the membership to the CPR and CTS until 28th...

Read more
Insider Insights
21.02.2022
CNAM spending on reimbursed medicines

Reimbursed spending by the CNAM on out-patient care (including care from general practitioners [GPs]...

Read more
Insider Insights
16.02.2022
AIFA announces reimbursement of oral SMA treatment

The Italian Medicines Agency (AIFA) has announced that Roche’s Evyrsdi (risdiplam) is reimbursed w...

Read more
Insider Insights
10.02.2022
Reimbursement rate of gliptins revised downwards

In line with legislation published in the Official Journal (Journal Officiel) on 1st February 2022, ...

Read more
Insider Insights
01.02.2022
Increasing prescribing controls on new medicines

According to data from the Ministry of Health 65.1% of medicines admitted to reimbursement in 2021 w...

Read more
Insider Insights
01.02.2022
Prescribing controls on new medicines

The Ministry of Health reports that 65.1% of medicines admitted to reimbursement in 2021 were subjec...

Read more
Publications
03.12.2021
Pricing and reimbursement policies for digital the

Digital therapeutics (DTx) is a category of digital health, which is defined as products that delive...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.